Literature DB >> 3088649

A conditioned anti-parkinsonian drug effect in the hemi-parkinsonian rat.

R J Carey.   

Abstract

In two separate experiments contralateral rotation was classically conditioned in hemi-Parkinsonian rats. In the first experiment, ten rats with unilateral 6-hydroxydopamine lesions of the substantia nigra, which produced ipsiversive circling, were given five daily injections of the dopamine receptor agonist apomorphine (0.5 mg/kg) to induce circling contralateral to the lesion hemisphere. One half of the rats (the conditioning group) were placed in a novel environment for 15 min during each apomorphine treatment. Subsequently, when placed into this environment 3, 10, 17, and 24 days after the final apomorphine injection, the conditioning group spontaneously rotated contralateral to the lesion hemisphere, whereas a similarly drug-treated non-conditioned group spontaneously rotated ipsilateral to the lesion hemisphere. On day 26, all rats were given a 2.0 mg/kg injection of d-amphetamine, which generated ipsilateral rotation in all rats in their home environment, but when placed in the conditioning environment, the conditioned group rotated contralateral whereas the non-conditioned group rotated ipsilateral. In the second experiment, eight rats with unilateral destruction of dopamine neurons were given differential conditioning in two novel environments. In every case, environments associated with 0.5 mg/kg apomorphine treatment induced contralateral rotation when the rats were tested without drug but ipsilateral rotation in environments not associated with apomorphine. These findings suggest a role for respondent or Pavlovian conditioning in the pharmacological management of Parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088649     DOI: 10.1007/bf00174357

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

2.  Central deopaminergic receptor supersensitivity and its relevance to Parkinson's disease.

Authors:  C J Pycock; C D Marsden
Journal:  J Neurol Sci       Date:  1977 Jan-Feb       Impact factor: 3.181

3.  Conditioned turning in rats: dopaminergic involvement in the initiation of movement rather than the movement itself.

Authors:  S B Dunnett; A Björklund
Journal:  Neurosci Lett       Date:  1983-10-31       Impact factor: 3.046

4.  Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250

5.  Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.

Authors:  I Creese; S H Snyder
Journal:  Eur J Pharmacol       Date:  1979-06-15       Impact factor: 4.432

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 7.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

8.  Pavlovian conditional tolerance to haloperidol catalepsy: evidence of dynamic adaptation in the dopaminergic system.

Authors:  C X Poulos; R Hinson
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

9.  Pharmacological basis of akinesia in Parkinson's disease.

Authors:  H Narabayashi
Journal:  J Neural Transm Suppl       Date:  1983

10.  Behavioral and biochemical evidence of apomorphine-induced supersensitivity of the striatal dopamine receptors.

Authors:  P Deshaies; P Bédard; P Falardeau; T Di Paolo
Journal:  Neuropharmacology       Date:  1984-10       Impact factor: 5.250

View more
  3 in total

Review 1.  Behavioural consequences of neural transplantation.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

2.  Pavlovian conditioning of L-dopa induced movement.

Authors:  R J Carey
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson's Disease.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Irene Reyes-Resina; Gemma Navarro; Eva Martínez-Pinilla
Journal:  Front Aging Neurosci       Date:  2020-03-12       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.